Acute Porphyria Drugs

Monograph

C07AA07 - Sotalol
Not porphyrinogenic
NP

Rationale
Beta-blocker, not metabolised. Occasional clinical observation of tolerance. Two references state non-porphyrinogenicity.
Chemical description
Watersoluble beta-receptor blocking substance. Excreted unchanged in urine. Thunell, patient reports (n=3 ): tolerated. South African list: use. French list: authorized. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.
References
Tradenames

Sotalol Sotalex · Sotalol Sotalol · Sotapor Sotalex Rytmobeta · Sotalex · Sotalolo Darob · Sotagamma · Sotalol Sotalol Beta-Cardone · Sotacor · Sotalol Sotalol Sotalol Biosotal · Sotahexal · Sotalol Sotalex Sotalol Sotacor · Sotalol Sotagamma Sotahexal Darob Darob · Loritmik · Sotalolijev Sotalol
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙